Real-time enrollment status for this type 2 diabetes clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT07064473 |
| Recruiting Status | Recruiting |
| Condition | Type 2 Diabetes |
| Phase | PHASE3 |
| Target Enrollment | 11,800 participants |
| Active Locations | 208 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | September 30, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07064473 is currently recruiting participants. This phase3 study for type 2 diabetes is actively seeking new participants at 208 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07064473 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 208 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07064473 was last updated 1 week ago (September 30, 2026). HelloStudys verifies this status automatically.